Using Real-World Data (RWD) From An Integrated Platform For Rapid Analysis Of Individuals With Cancer With & Without COVID-19 Across Distinct Health Systems

In July 2020, researchers at U.S. Food and Drug Administration and Syapse published findings based on an analysis of more than 212,000 health records of people living with cancer across two major health systems in the Midwestern United States. The analysis showed people diagnosed with cancer who contract coronavirus disease 2019 (COVID-19) have a higher risk of hospitalization and death compared to people without cancer . . .